Category Archives: metabolic
False-positive breath-alcohol test after a ketogenic diet
A biochemistry reminder from the International Journal of Obesity (2007) 31, 559–561. Abstract: A 59-year-old man undergoing weight loss with very low calorie diets (VLCD) attempted to drive a car, which was fitted with an alcohol ignition interlock device, but … Continue reading →
Stress may disturb the blood-brain barrier
Stress may disturb the blood-brain barrier BMJ 1996; 313 doi: 10.1136/bmj.313.7071.1505a (Published 14 December 1996) Cite this as: BMJ 1996;313:1505.2 Severe stress can disturb the blood-brain barrier that protects the brain from drugs and other chemicals that enter the … Continue reading →
SSRIs should be considered in the list of medications that are risk factors for osteoporotic fractures.
Not really news but still an important pharmacovigilance paper. As has been correctly pointed out, relevant to the changing informed consent & decision making landscape. More on the subject matter at http://www.ncbi.nlm.nih.gov/pubmed/17592097 Bone. 2012 Sep;51(3):606-13. Epub 2012 May 30. Antidepressant … Continue reading →
A role for vitamin D in the treatment of multiple sclerosis (MS)
This is such an important topic that I am posting the full-length article. On pubmed at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882221/?tool=pubmed. Neurology. 2010 June 8; 74(23): 1852–1859. doi: 10.1212/WNL.0b013e3181e1cec2 PMCID: PMC2882221 A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis … Continue reading →
Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial.
================================================ Nutr Metab (Lond). 2009 Aug 10;6:31. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Henderson ST, Vogel JL, Barr LJ, Garvin F, Jones JJ, Costantini LC. Source Accera, … Continue reading →
Maurice Preter, MD
Maurice Preter, MD is a European and U.S. educated psychiatrist, psychotherapist, psychopharmacologist, neurologist, and medical-legal expert in private practice in Manhattan. He is also the principal of Fifth Avenue Concierge Medicine, PLLC, a medical concierge service and health advisory for select individuals and families.